These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection. Randolph AG; Yip WK; Allen EK; Rosenberger CM; Agan AA; Ash SA; Zhang Y; Bhangale TR; Finkelstein D; Cvijanovich NZ; Mourani PM; Hall MW; Su HC; Thomas PG; ; J Infect Dis; 2017 Jul; 216(1):14-21. PubMed ID: 28531322 [TBL] [Abstract][Full Text] [Related]
49. Histone demethylase LSD1 restricts influenza A virus infection by erasing IFITM3-K88 monomethylation. Shan J; Zhao B; Shan Z; Nie J; Deng R; Xiong R; Tsun A; Pan W; Zhao H; Chen L; Jin Y; Qian Z; Lui K; Liang R; Li D; Sun B; Lavillette D; Xu K; Li B PLoS Pathog; 2017 Dec; 13(12):e1006773. PubMed ID: 29281729 [TBL] [Abstract][Full Text] [Related]
50. Ethnic variation in risk genotypes based on single nucleotide polymorphisms (SNPs) of the interferon-inducible transmembrane 3 (IFITM3) gene, a susceptibility factor for pandemic 2009 H1N1 influenza A virus. Kim YC; Jeong BH Immunogenetics; 2020 Dec; 72(9-10):447-453. PubMed ID: 33174121 [TBL] [Abstract][Full Text] [Related]
51. Rapid interferon independent expression of IFITM3 following T cell activation protects cells from influenza virus infection. Bedford JG; O'Keeffe M; Reading PC; Wakim LM PLoS One; 2019; 14(1):e0210132. PubMed ID: 30650117 [TBL] [Abstract][Full Text] [Related]
53. A Knockout of the IFITM3 Gene Increases the Sensitivity of WI-38 VA13 Cells to the Influenza A Virus. Eshchenko N; Sergeeva M; Zhuravlev E; Kudria K; Goncharova E; Komissarov A; Stepanov G Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203797 [TBL] [Abstract][Full Text] [Related]
54. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. Weidner JM; Jiang D; Pan XB; Chang J; Block TM; Guo JT J Virol; 2010 Dec; 84(24):12646-57. PubMed ID: 20943977 [TBL] [Abstract][Full Text] [Related]
55. Pan Y; Yang P; Dong T; Zhang Y; Shi W; Peng X; Cui S; Zhang D; Lu G; Liu Y; Wu S; Wang Q Front Cell Infect Microbiol; 2017; 7():294. PubMed ID: 28713779 [No Abstract] [Full Text] [Related]
56. Late Endosomal/Lysosomal Cholesterol Accumulation Is a Host Cell-Protective Mechanism Inhibiting Endosomal Escape of Influenza A Virus. Kühnl A; Musiol A; Heitzig N; Johnson DE; Ehrhardt C; Grewal T; Gerke V; Ludwig S; Rescher U mBio; 2018 Jul; 9(4):. PubMed ID: 30042202 [TBL] [Abstract][Full Text] [Related]
57. IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein. Yu J; Li M; Wilkins J; Ding S; Swartz TH; Esposito AM; Zheng YM; Freed EO; Liang C; Chen BK; Liu SL Cell Rep; 2015 Oct; 13(1):145-156. PubMed ID: 26387945 [TBL] [Abstract][Full Text] [Related]
58. Bat and pig IFN-induced transmembrane protein 3 restrict cell entry by influenza virus and lyssaviruses. Benfield CTO; Smith SE; Wright E; Wash RS; Ferrara F; Temperton NJ; Kellam P J Gen Virol; 2015 May; 96(Pt 5):991-1005. PubMed ID: 25614588 [TBL] [Abstract][Full Text] [Related]
59. Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity. David S; Correia V; Antunes L; Faria R; Ferrão J; Faustino P; Nunes B; Maltez F; Lavinha J; Rebelo de Andrade H Immunogenetics; 2018 Mar; 70(3):169-177. PubMed ID: 28842783 [TBL] [Abstract][Full Text] [Related]
60. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Amini-Bavil-Olyaee S; Choi YJ; Lee JH; Shi M; Huang IC; Farzan M; Jung JU Cell Host Microbe; 2013 Apr; 13(4):452-64. PubMed ID: 23601107 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]